The role of interleukin-8 and other cytokines in the pathogenesis of Felty's syndrome
- PMID: 7554553
The role of interleukin-8 and other cytokines in the pathogenesis of Felty's syndrome
Abstract
Objective: Felty's syndrome (FS) is defined as rheumatoid arthritis (RA) with neutropenia and, in some cases, splenomegaly; the outcome is primarily determined by the risk of infection, which is related to the degree of neutropenia. We analysed whether the clinical manifestations of FS, especially neutropenia, could be explained by abnormalities in cytokine production.
Methods: We examined the production in FS of five cytokines involved in the maturation and activation of polymorphonuclear cells (PMNs): IL-1 beta, TNF alpha, IL-8, G-CSF and GM-CSF. Because of the role of systemic IL-8 in neutrophil migration, serum IL-8 levels were also evaluated.
Results: Spontaneous and anti-CD16 stimulated cytokine production was similar in FS, RA and healthy controls (NC). However, anti-CD3 stimulated IL-8 production was significantly increased compared to NC in both RA and FS. FS patients who spontaneously produced G-CSF in culture were protected from bacterial infections. Serum IL-8 levels were elevated in FS and RA compared to NC (p < 0.001 for both groups). In FS, serum IL-8 was higher in patients with a history of bacterial infections compared to those without (p < 0.01) and there was a weak inverse correlation between neutropenia and serum IL-8 levels (Kendal's tau B = -0.31, p = 0.05).
Conclusion: The neutropenia of FS cannot be explained by changes in peripheral blood cytokine production, although changes in the bone marrow microenvironment cannot be excluded. Our data do suggest a possible role for G-CSF and IL-8 in the development of certain FS complications.
Similar articles
-
Low Fcgamma receptor III and high granulocyte colony-stimulating factor serum levels correlate with the risk of infection in neutropenia due to Felty's syndrome or systemic lupus erythematosus.Am J Med. 2002 Aug 1;113(2):134-9. doi: 10.1016/s0002-9343(02)01161-0. Am J Med. 2002. PMID: 12133752
-
Autoantibodies against granulocyte colony-stimulating factor in Felty's syndrome and neutropenic systemic lupus erythematosus.Arthritis Rheum. 2002 Sep;46(9):2384-91. doi: 10.1002/art.10497. Arthritis Rheum. 2002. PMID: 12355486
-
Treatment of severe neutropenia due to Felty's syndrome or systemic lupus erythematosus with granulocyte colony-stimulating factor.Semin Arthritis Rheum. 1999 Oct;29(2):82-99. doi: 10.1016/s0049-0172(99)80040-7. Semin Arthritis Rheum. 1999. PMID: 10553980 Review.
-
Use of colony-stimulating factors in the treatment of neutropenia associated with collagen vascular disease.Curr Opin Hematol. 1997 May;4(3):196-9. doi: 10.1097/00062752-199704030-00007. Curr Opin Hematol. 1997. PMID: 9209836 Review.
-
Autoantibodies against granulocyte-macrophage colony stimulating factor and interleukin-3 are rare in patients with Felty's syndrome.Ann Rheum Dis. 2004 Jul;63(7):862-6. doi: 10.1136/ard.2003.011056. Ann Rheum Dis. 2004. PMID: 15194585 Free PMC article.
Cited by
-
Felty's Syndrome, Insights and Updates.Open Rheumatol J. 2014 Dec 31;8:129-36. doi: 10.2174/1874312901408010129. eCollection 2014. Open Rheumatol J. 2014. PMID: 25614773 Free PMC article.
-
Neutropaenia and splenomegaly without arthritis: think rheumatoid arthritis.BMJ Case Rep. 2018 Jul 11;2018:bcr2018225359. doi: 10.1136/bcr-2018-225359. BMJ Case Rep. 2018. PMID: 30002215 Free PMC article. Review.
-
Primary and secondary autoimmune neutropenia.Arthritis Res Ther. 2005;7(5):208-14. doi: 10.1186/ar1803. Epub 2005 Aug 31. Arthritis Res Ther. 2005. PMID: 16207350 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical